"Prescription Fees" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The charge levied on the consumer for drugs or therapy prescribed under written order of a physician or other health professional.
| Descriptor ID |
D011306
|
| MeSH Number(s) |
N03.219.442.551.621
|
| Concept/Terms |
Prescription Fees- Prescription Fees
- Dispensing Fees
- Dispensing Fee
- Fee, Dispensing
- Fees, Dispensing
- Fees, Prescription
- Fee, Prescription
- Prescription Fee
|
Below are MeSH descriptors whose meaning is more general than "Prescription Fees".
Below are MeSH descriptors whose meaning is more specific than "Prescription Fees".
This graph shows the total number of publications written about "Prescription Fees" by people in this website by year, and whether "Prescription Fees" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prescription Fees" by people in Profiles.
-
Improving the Affordability of Prescription Medications for People with Chronic Respiratory Disease. An Official American Thoracic Society Policy Statement. Am J Respir Crit Care Med. 2018 12 01; 198(11):1367-1374.
-
Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries. J Clin Oncol. 2017 Aug 01; 35(22):2482-2489.
-
Identifying patients with cost-related medication non-adherence: a big-data approach. J Med Econ. 2016 Aug; 19(8):806-11.
-
Overspending driven by oversized single dose vials of cancer drugs. BMJ. 2016 Feb 29; 352:i788.
-
Pharmaceutical Policy Reform--Balancing Affordability with Incentives for Innovation. N Engl J Med. 2016 Feb 25; 374(8):703-6.
-
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000.
-
Enhancing prescription drug innovation and adoption. Ann Intern Med. 2011 Jun 21; 154(12):833-7, W-301.
-
What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens (Greenwich). 2008 Jan; 10(1 Suppl 1):20-6.
-
Ensuring fairness in coverage decisions: applying the American Medical Association Ethical Force Program's consensus report to managed care pharmacy. Am J Health Syst Pharm. 2006 Sep 15; 63(18):1749-54.
-
Physician strategies to reduce patients' out-of-pocket prescription costs. Arch Intern Med. 2005 Mar 28; 165(6):633-6.